Navigation

    Forum

    • Register
    • Login
    • Search
    • Categories
    • Recent
    • Popular
    • Users
    • Groups

    Unbranded disease mechanism APS for first-in-class product

    Non-product branded APS, pre-NOC teasers
    2
    2
    117
    Loading More Posts
    • Oldest to Newest
    • Newest to Oldest
    • Most Votes
    Reply
    • Reply as topic
    Log in to reply
    This topic has been deleted. Only users with topic management privileges can see it.
    • S
      Stet last edited by

      If a product has been recently approved with a novel mechanism of action that targets (for example) a unique signalling pathway, is it acceptable to create an unbranded HCP-directed mechanism of disease APS that focuses on that pathway?

      Or would that inherently brand the APS as there is only one treatment available targeting that mechanism of disease?

      Jennifer Carroll 1 Reply Last reply Reply Quote 0
      • Jennifer Carroll
        Jennifer Carroll @Stet last edited by

        @stet

        An unbranded APS may be created for physiology or pathophysiology of the signaling pathway. However, the APS may not make reference to potential treatment or exogenous intervention at the target site as that would brand the APS if there are no other agents that work at that target.

        1 Reply Last reply Reply Quote 1
        • First post
          Last post